Emilio Yángüez

Dr. Emilio Yángüez


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
STShashank Tripathi
Shashank Tripathi
MPMarie O. Pohl
Marie O. Pohl
YZYingyao Zhou
Yingyao Zhou
ARAriel Rodriguez-Frandsen
Ariel Rodriguez-Frandsen
GWGuojun Wang
Guojun Wang
SCSumit K. Chanda
Sumit K. Chanda

10 January 2024 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
AVAlberto Valdeolivas
Alberto Valdeolivas
BABettina Amberg
Bettina Amberg
NGNicolas Giroud
Nicolas Giroud
MRMarion Richardson
Marion Richardson
EGEric J. C. Gálvez
Eric J. C. Gálvez
KHKerstin Hahn
Kerstin Hahn
The consensus molecular subtypes (CMS) of colorectal cancer (CRC) is the most widely-used gene expression-based classification and has contributed to a better understanding of disease heterogeneity and prognosis. Nevertheless, CMS intratumoral heterogeneity restricts its clinical application, stressing the necessity of further characterizing the composition and architecture of CRC. Here, we used Spatial Transcriptomics (ST) in combination with single-cell RNA sequencing (scRNA-seq) to decipher the spatially resolved cellular and molecular composition of CRC. In addition to mapping the intratumoral heterogeneity of CMS and their microenvironment, we identified cell communication events in the tumor-stroma interface of CMS2 carcinomas. This includes tumor growth-inhibiting as well as -activating signals, such as the potential regulation of the ETV4 transcriptional activity by DCN or the PLAU-PLAUR ligand-receptor interaction. Our study illustrates the potential of ST to resolve CRC molecular heterogeneity and thereby help advance personalized therapy.

20 February 2019 in Nature
Verified
Journal Article
Closed access
PDF file
UKUmut Karakus
Umut Karakus
TTThiprampai Thamamongood
Thiprampai Thamamongood
KCKevin Ciminski
Kevin Ciminski
WRWei Ran
Wei Ran
SGSira C. Günther
Sira C. Günther
SSSilke Stertz
Silke Stertz

19 August 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EYEmilio Yángüez
Emilio Yángüez
ACAna B. Castro-Sanz
Ana B. Castro-Sanz
NFNuria Fernández-Bautista
Nuria Fernández-Bautista
JOJuan C. Oliveros
Juan C. Oliveros
MCM. Mar Castellano
M. Mar Castellano
Heat stress is one of the most prominent and deleterious environmental threats affecting plant growth and development. Upon high temperatures, plants launch specialized gene expression programs that promote stress protection and survival. These programs involve global and specific changes at the transcriptional and translational levels. However, the coordination of these processes and their specific role in the establishment of the heat stress response is not fully elucidated. We have carried out a genome-wide analysis to monitor the changes in the translation efficiency of individual mRNAs of Arabidopsis thaliana seedlings after the exposure to a heat shock stress. Our results demonstrate that translation exerts a wide but dual regulation of gene expression. For the majority of mRNAs, translation is severely repressed, causing a decreased of 50% in the association of the bulk of mRNAs to polysomes. However, some relevant mRNAs involved in different aspects of homeostasis maintenance follow a differential pattern of translation. Sequence analyses of the differentially translated mRNAs unravels that some features, such as the 5′UTR G+C content and the cDNA length, may take part in the discrimination mechanisms for mRNA polysome loading. Among the differentially translated genes, master regulators of the stress response stand out, highlighting the main role of translation in the early establishment of the physiological response of plants to elevated temperatures.

1 October 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
MPMarc Pfefferlé
Marc Pfefferlé
GIGiada Ingoglia
Giada Ingoglia
CSChristian A. Schaer
Christian A. Schaer
AYAyla Yalamanoglu
Ayla Yalamanoglu
RBRaphael Buzzi
Raphael Buzzi
FVFlorence Vallelian
Florence Vallelian
During hemolysis, macrophages in the liver phagocytose damaged erythrocytes to prevent the toxic effects of cell-free hemoglobin and heme. It remains unclear how this homeostatic process modulates phagocyte functions in inflammatory diseases. Using a genetic mouse model of spherocytosis and single-cell RNA sequencing, we found that erythrophagocytosis skewed liver macrophages into an antiinflammatory phenotype that we defined as MarcohiHmoxhiMHC class IIlo erythrophagocytes. This phenotype transformation profoundly mitigated disease expression in a model of an anti-CD40–induced hyperinflammatory syndrome with necrotic hepatitis and in a nonalcoholic steatohepatitis model, representing 2 macrophage-driven sterile inflammatory diseases. We reproduced the antiinflammatory erythrophagocyte transformation in vitro by heme exposure of mouse and human macrophages, yielding a distinctive transcriptional signature that segregated heme-polarized from M1- and M2-polarized cells. Mapping transposase-accessible chromatin in single cells by sequencing defined the transcription factor NFE2L2/NRF2 as a critical driver of erythrophagocytes, and Nfe2l2/Nrf2 deficiency restored heme-suppressed inflammation. Our findings point to a pathway that regulates macrophage functions to link erythrocyte homeostasis with innate immunity.

28 June 2023 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
GLGabrielle Leclercq-Cohen
Gabrielle Leclercq-Cohen
NSNathalie Steinhoff
Nathalie Steinhoff
LSLlucia Albertí Servera
Llucia Albertí Servera
SNSina Nassiri
Sina Nassiri
SDSabrina Danilin
Sabrina Danilin
MBMarina Bacac
Marina Bacac
Purpose: Target-dependent TCB activity can result in the strong and systemic release of cytokines that may develop into cytokine release syndrome (CRS), highlighting the need to understand and prevent this complex clinical syndrome. Experimental Design: We explored the cellular and molecular players involved in TCB-mediated cytokine release by single-cell RNA-sequencing of whole blood treated with CD20-TCB together with bulk RNA-sequencing of endothelial cells exposed to TCB-induced cytokine release. We used the in vitro whole blood assay and an in vivo DLBCL model in immunocompetent humanized mice to assess the effects of dexamethasone, anti-TNFα, anti-IL6R, anti-IL1R, and inflammasome inhibition, on TCB-mediated cytokine release and antitumor activity. Results: Activated T cells release TNFα, IFNγ, IL2, IL8, and MIP-1β, which rapidly activate monocytes, neutrophils, DCs, and NKs along with surrounding T cells to amplify the cascade further, leading to TNFα, IL8, IL6, IL1β, MCP-1, MIP-1α, MIP-1β, and IP-10 release. Endothelial cells contribute to IL6 and IL1β release and at the same time release several chemokines (MCP-1, IP-10, MIP-1α, and MIP-1β). Dexamethasone and TNFα blockade efficiently reduced CD20-TCB–mediated cytokine release whereas IL6R blockade, inflammasome inhibition, and IL1R blockade induced a less pronounced effect. Dexamethasone, IL6R blockade, IL1R blockade, and the inflammasome inhibitor did not interfere with CD20-TCB activity, in contrast to TNFα blockade, which partially inhibited antitumor activity. Conclusions: Our work sheds new light on the cellular and molecular players involved in cytokine release driven by TCBs and provides a rationale for the prevention of CRS in patients treated with TCBs. See related commentary by Luri-Rey et al., p. 4320